Literature DB >> 16492422

Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.

Paul G Hammerness1, Fé M Vivas, Daniel A Geller.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16492422     DOI： 10.1016/j.jpeds.2005.09.028

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder.

Authors:  Evelyn D Lobo; Tonya Quinlan; Apurva Prakash
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

Review 2.  Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners.

Authors:  Dilip R Patel; Cynthia Feucht; Kelly Brown; Jessica Ramsay
Journal:  Transl Pediatr       Date:  2018-01

3.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 4.  Advances in the treatment of fragile X syndrome.

Authors:  Randi J Hagerman; Elizabeth Berry-Kravis; Walter E Kaufmann; Michele Y Ono; Nicole Tartaglia; Ave Lachiewicz; Rebecca Kronk; Carol Delahunty; David Hessl; Jeannie Visootsak; Jonathan Picker; Louise Gane; Michael Tranfaglia
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

Review 5.  Management of treatment-resistant depression in children and adolescents.

Authors:  Melissa DeFilippis; Karen Dineen Wagner
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.